Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
29.03. | Mineralys Therapeutics, Inc.: Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology's ... | 155 | GlobeNewswire (Europe) | - Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and 7.9 mmHg placebo-adjusted reduction (p=0.001), assessed by 24hr ABPM at week 12, with favorable safety and tolerability profile... ► Artikel lesen | |
29.03. | Novo Nordisk A/S: Rybelsus (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025 | 1.036 | GlobeNewswire (Europe) | Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial1.Data... ► Artikel lesen | |
29.03. | Novo Nordisk A/S: Ozempic (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025 | 862 | GlobeNewswire (Europe) | Ozempic® improved maximum walking distance by 13% vs placebo in adults with type 2 diabetes and peripheral artery disease (PAD) in the phase 3 STRIDE trial1.Data were presented at the American College... ► Artikel lesen | |
29.03. | Helios Fairfax Partners Corporation: Financial Results for the Fourth Quarter of 2024 | 1.152 | GlobeNewswire (Europe) | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) today announced... ► Artikel lesen | |
29.03. | Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results | 325 | GlobeNewswire (Europe) | SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. ("Turnstone" or the "Company") (Nasdaq: TSBX), a biotechnology company historically focused on the development of a differentiated... ► Artikel lesen | |
29.03. | Osisko Development Corp.: Osisko Development Reports Fourth Quarter and Year-End 2024 Results | 407 | GlobeNewswire (Europe) | (All dollar amounts are expressed in Canadian dollars, unless stated otherwise) MONTREAL, March 28, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or... ► Artikel lesen | |
29.03. | Partners Value Split Corp. Announces 2024 Annual Results | 1.555 | GlobeNewswire (Europe) | TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Partners Value Split Corp. (the "Company", TSX: PVS.PR.G, PVS.PR.H, PVS.PR.I, PVS.PR.J, PVS.PR.K, PVS.PR.L) announced today that the net asset value per... ► Artikel lesen | |
29.03. | HYTN Innovations Inc.: HYTN Secures Strategic Supply Agreements and Qualifies 4000kg of Cannabis for German Market | 583 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, March 28, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing... ► Artikel lesen | |
29.03. | Summit State Bank Reports Revised Fourth Quarter 2024 Financial Results | 265 | GlobeNewswire (Europe) | SANTA ROSA, Calif., March 28, 2025 (GLOBE NEWSWIRE) -- Summit State Bank (the "Bank") (Nasdaq: SSBI) today reported that it has revised its fourth quarter and full year 2024 financial results from... ► Artikel lesen | |
29.03. | Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates | 501 | GlobeNewswire (Europe) | SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 3.015 |
APPLE | 2.123 |
STEYR MOTORS | 1.955 |
RHEINMETALL | 1.715 |
BYD | 1.535 |
RENK GROUP | 1.296 |
TESLA | 1.241 |
TUI | 1.191 |
DEUTZ | 1.102 |
NEL | 889 |
NOVO NORDISK | 734 |
EVOTEC | 729 |
INFINEON | 704 |
BASF | 669 |
BAYER | 625 |
MERCEDES-BENZ | 619 |
DEUTSCHE BANK | 610 |
XIAOMI | 600 |
MUTARES | 568 |
THYSSENKRUPP | 566 |
AMAZON | 555 |
COMMERZBANK | 555 |
DEUTSCHE TELEKOM | 555 |
ALLIANZ | 554 |
VOLKSWAGEN | 554 |